Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,357 Cr
Revenue (TTM)
₹294 Cr
Net Profit (TTM)
₹33 Cr
ROE
15.9 %
ROCE
24.9 %
P/E Ratio
40.8
P/B Ratio
5.7
Industry P/E
41.55
EV/EBITDA
14.1
Div. Yield
0 %
Debt to Equity
0
Book Value
₹45.6
EPS
₹6.4
Face value
2
Shares outstanding
52,080,758
CFO
₹319.43 Cr
EBITDA
₹408.63 Cr
Net Profit
₹140.99 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Suraksha Diagnostic
| -3.5 | -7.2 | -4.6 | -10.5 | -- | -- | -- |
|
BSE Healthcare
| -2.6 | -1.7 | -3.7 | 3.2 | 25.2 | 15.5 | 10.7 |
|
Company
|
2025
|
|---|---|
|
Suraksha Diagnostic
| -29.1 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Suraksha Diagnostic
|
260.3 | 1,357.5 | 294.1 | 32.4 | 17.4 | 15.1 | 40.8 | 5.7 |
| 250.0 | 611.3 | 230.1 | 23.5 | -- | 28.7 | 27.6 | 4.8 | |
| 1,308.2 | 21,953.1 | 2,662.8 | 533.1 | 22.9 | 24.1 | 41.6 | 8.6 | |
| 645.1 | 25,893.0 | 3,626.9 | 315.0 | 15.0 | 13.3 | 86.1 | 11.1 | |
| 587.7 | 1,901.1 | 766.3 | 80.5 | 15.7 | 8.9 | 23.6 | 2.0 | |
| 441.1 | 9,109.0 | 1,566.5 | 169.5 | 14.8 | 12.7 | 54.1 | 6.0 | |
| 532.9 | 5,339.1 | 755.8 | 67.1 | -- | 13.8 | 79.6 | 5.5 | |
| 287.9 | 899.4 | 1,231.3 | 29.1 | -4.7 | 4 | 34.6 | 1.3 | |
| 351.4 | 5,616.9 | 792.3 | 135.5 | 23.5 | 26.4 | 40.8 | 8.4 | |
| 904.6 | 8,724.3 | 768.1 | 159.9 | 29.2 | 19.3 | 54.7 | 9.6 |
No Review & Analysis are available.
--
Incorporated
2005
Chairman
Somnath Chatterjee
Managing Director
--
Headquarters
Kolkata, West Bengal
Website
Looking for more details about Suraksha Diagnostic Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Suraksha Diagnostic Ltd is ₹260.30 (NSE) and ₹260.65 (BSE) as of 20-Mar-2026 IST. Suraksha Diagnostic Ltd has given a return of -10.55% in the last 1 years.
The P/E ratio of Suraksha Diagnostic Ltd is 40.77 times as on 20-Mar-2026, a 2 discount to its peers’ median range of 41.55 times.
The P/B ratio of Suraksha Diagnostic Ltd is 5.71 times as on 20-Mar-2026, a 20 discount to its peers’ median range of 7.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
42.19
|
6.36
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Suraksha Diagnostic Ltd are Rs 352.50 and Rs 240.00 as of 22-Mar-2026.
Suraksha Diagnostic Ltd has a market capitalisation of ₹ 1,357 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Suraksha Diagnostic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹6.90
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.